Related Experiment Video
Updated: Jan 19, 2026

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors
Published on: February 27, 2015
Review of Issues and Solutions to Data Analysis Reproducibility and Data Quality in Clinical Proteomics
Mathias Walzer1, Juan Antonio Vizcaíno2
1European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Cambridge, UK.
Abstract:
In any analytical discipline, data analysis reproducibility is closely interlinked with data quality. In this book chapter focused on mass spectrometry-based proteomics approaches, we introduce how both data analysis reproducibility and data quality can influence each other and how data quality and data analysis designs can be used to increase robustness and improve reproducibility. We first introduce methods and concepts to design and maintain robust data analysis pipelines such that reproducibility can be increased in parallel. The technical aspects related to data analysis reproducibility are challenging, and current ways to increase the overall robustness are multifaceted. Software containerization and cloud infrastructures play an important part.We will also show how quality control (QC) and quality assessment (QA) approaches can be used to spot analytical issues, reduce the experimental variability, and increase confidence in the analytical results of (clinical) proteomics studies, since experimental variability plays a substantial role in analysis reproducibility. Therefore, we give an overview on existing solutions for QC/QA, including different quality metrics, and methods for longitudinal monitoring. The efficient use of both types of approaches undoubtedly provides a way to improve the experimental reliability, reproducibility, and level of consistency in proteomics analytical measurements.
More Related Videos
14:51Comprehensive Workflow of Mass Spectrometry-based Shotgun Proteomics of Tissue Samples
Published on: November 13, 2021
09:52A Clinical Metaproteomics Workflow Implemented within Galaxy Bioinformatics Platform to Analyze Host-Microbiome Interactions Underlying Human Disease
Published on: January 10, 2025